Endometriosis affects up to 10% of women of reproductive age. We are developing a suite of breakthrough tests including HerResolveTM, a non-invasive miRNA panel-based test for the detection and confirmation of endometriosis.
Globally, 17.5% of the adult population suffers from infertility. In the United States, 11% of women of reproductive age have experienced fertility problems. Heranova is creating tests and treatments that can improve women’s chances of having a successful outcome.